论文部分内容阅读
目的探讨新生儿硬肿症的临床治疗效果。方法将96例新生儿硬肿症患儿随机分为治疗组50例,对照组46例,两组均采用常规综合治疗,治疗组在对照组治疗基础上加参附液2ml/(kg·d)静脉滴注,5～7d为一个疗程,观察两组新生儿的体温恢复时间、硬肿消散时间。结果治疗组硬肿完全消退时间为(3.61±0.29)d,体温恢复时间为(5.95±1.54)d,住院时间为(7.58±1.42)d,与对照组相比差异均有统计学意义(P<0.05)。结论参附液治疗新生儿硬肿症可使硬肿消散和体温恢复增快,其疗效显著,操作简单方便,经济。
Objective To investigate the clinical effect of neonatal sclerema. Methods A total of 96 neonates with scleroderma were randomly divided into treatment group (n = 50) and control group (n = 46). The two groups were treated by conventional combination therapy. The treatment group was treated with Shenfu solution 2ml / (kg · d ) Intravenous drip, 5 ~ 7d for a course of treatment, observed two groups of newborns body temperature recovery time, edema dissipated time. Results The complete remission of the treatment group was (3.61 ± 0.29) d, the recovery time of body temperature was (5.95 ± 1.54) days and the hospitalization time was (7.58 ± 1.42) days, the difference was statistically significant compared with the control group (P <0.05). Conclusion Shenfu liquid treatment of neonatal sclera can dissipate the sclerosis and body temperature faster recovery, the effect is significant, the operation is simple and convenient and economical.